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Summary
The mechanism of DNA replication initiation and
progression is poorly understood in the parasites,
including human malaria parasite Plasmodium
falciparum. Using bioinformatics tools and yeast
complementation assay, we identiﬁed a putative
homologue of Saccharomyces cerevisiae origin rec-
ognition complex subunit 5 in P. falciparum (PfORC5).
PfORC5 forms distinct nuclear foci colocalized with
the replication foci marker proliferating cell nuclear
antigen (PfPCNA) and co-immunoprecipitates with
PCNA during early-to-mid trophozoite stage replicat-
ing parasites. Interestingly, these proteins separate
from each other at the non-replicating late schizont
stage, citing the evidence of the presence of both
PCNA and ORC components in replication foci during
eukaryotic DNA replication. PfORC1, another ORC
subunit, colocalizes with PfPCNA and PfORC5 at the
beginning of DNA replication, but gets degraded at
the late schizont stage, ensuring the regulation of
DNA replication in the parasites. Further, we have
identiﬁed putative PCNA-interacting protein box in
PfORC1 that may explain in part the colocalization of
PfORC and PfPCNA. Additionally, use of speciﬁc DNA
replication inhibitor hydroxyurea affects ORC5/PCNA
foci formation and parasitic growth. These results
strongly favour replication factory model in the para-
sites and confer great potential to understand the
co-ordination between ORC and PCNA during eukary-
otic DNA replication in general.
Introduction
In eukaryotes, DNA replication takes place in subnuclear
foci termed as replication foci (Gilbert, 2001). These foci
contain several DNA replication accessory factors that
include, but are not limited to, DNA polymerases, prolifer-
ating cell nuclear antigen (PCNA), DNAligase, DNAmeth-
yltransferase, etc. (Leonhardt et al., 2000). It is believed
that each focus point harbours several replication forks
and the number may vary from 10 to 40 in metazoan cells
(Berezney et al., 2000; Cook, 2001). Analysis of a stable
mammalian cell line expressing low level of GFP-PCNA
and a similar strategy using GFP-PCNA expression in
Saccharamyces pombe reveal that the pattern and distri-
bution of replication foci change with progression through
S phase in eukaryotes (Leonhardt et al., 2000; Meister
et al., 2007).
A six-protein origin recognition complex (ORC), con-
served from yeast to mammals, binds to the DNA replica-
tion sites followed by concomitant binding of other
replication initiation and elongation factors like cdc6,
minichromosome maintenance proteins, cdt1, cdc45,
PCNA, DNA polymerase, etc. (Bell and Dutta, 2002).
Among these proteins, PCNA is considered to be the
marker for active replication foci as it interacts and
enhances the processivity of the DNA polymerase
enzymes (Moldovan et al., 2007). Attempts for complete
colocalization of ORC subunits with replication foci con-
taining PCNA has not been successful yet, probably
because of the fact that ORC subunits have different
functions other than DNA replication. While ORC1 might
have role in heterochromatin silencing, ORC2 and ORC6
are involved in centrosome copy number control and
cytokinesis respectively (Pak et al., 1997; Prasanth et al.,
2002; Prasanth et al., 2004).
Little is known regarding the control of DNA replication
in human malaria parasite Plasmodium falciparum. During
blood stage asexual development, each haploid merozo-
ite following invasion in red blood cell forms ring stage
parasite followed by trophozoite and multinucleated
mature schizont before releasing new merozoites in a
cycle of ~48 h. Based on studies on the incorporation of
radiolabelled precursors during in vitro P. falciparum
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synthesis starts in synchronized P. falciparum culture
~28–31 h after merozoite invasion and DNA content then
continues to increase for around 8–10 h (Inselburg and
Banyal, 1984; Graeser et al., 1996; Gantt et al., 1998;
Arnot and Gull, 1998) that include several rounds of DNA
replication. This is followed by the schizogony where four
to ﬁve nuclear divisions take place in the common cytosol
before the nuclei and other organelles are segregated into
new merozoites (Leete and Rubin, 1996).
The biochemistry and enzymology of nuclear Plasmo-
dium DNA replication has been restricted to the cloning
and characterization of some replication factors like
PfORC1, PfMCMs (mini-chromosome-maintenance
proteins), PfPCNA, PfRPA and few DNA polymerase
enzymes (Ridley et al., 1991; Kilbey et al., 1993; Patter-
son et al., 2002; Voss et al., 2002; Mehra et al., 2005;
Gupta et al., 2006; Patterson et al., 2006; Nunthawarasilp
et al., 2007). Few Plasmodium homologues of cyclins and
cdk-like kinases have been reported (Doerig et al., 2002;
Ward et al., 2004). Neither their roles in Plasmodium DNA
replication nor their cellular targets have been established
yet.
Because of the scarcity of knowledge regarding the
DNA replication machinery in Plasmodium, detailed
analysis and understanding of the replication components
are important. This may also be fruitful to ﬁnd suitable
targets for much needed novel intervention strategies.
We are particularly interested to identify new replication
factors in Plasmodium and their role in DNA replication
foci formation in P. falciparum during development. To
follow replication foci formation and progression during
parasite development, we have used two marker proteins,
namely ORC component and PCNA respectively. We
have recently reported the cloning and functional charac-
terization of P. falciparum ORC1 homologue that is essen-
tial for initiation of DNA replication (Mehra et al., 2005).
PfORC1 is expressed in the nucleus during trophozoite
and early schizont stages and the recombinant protein
shows ATPase activity, the hallmark of ORC function.
Apart from ORC1, ORC5 has also been reported to
contain ATP binding activity, essential for ORC activity
both in vivo and in vitro (Takahashi et al., 2004; Giordano-
Coltart et al., 2005). In addition to its conserved role in
DNA replication initiation, ORC1 has also been implicated
in heterochromatin silencing in higher eukaryotes (Pak
et al., 1997). After careful analysis of P. falciparum
genomic database, we have identiﬁed a putative PfORC5
homologue that gave us the opportunity to track the ORC
binding sites in P. falciparum.
In order to track the formation and progression of rep-
lication foci during different erythrocytic developmental
stages in P. falciparum, we used PfPCNA1 as a marker
for replication foci. The cloning and characterization of
PfPCNA1 was initially described in 1993 (Kilbey et al.,
1993). Although only one form of PCNA is found in S.
cerevisiae and mammals, two or three types of PCNA
have been reported recently in apicomplexan Toxoplasma
gondii, archaeans, higher plants and Drosophila (Hata
et al., 1992; Guerini et al. 2000; Daimon et al., 2002;
Ruike et al., 2006). These different forms of PCNA may
form homo- or hetero-trimeric sliding clamps with their
involvement in DNA replication or repair or both. Interest-
ingly, two PCNA homologues have been reported
(PfPCNA1 and PfPCNA2 respectively) in Plasmodium (Li
et al., 2002; Patterson et al., 2002). Although both the
PCNA are expressed during asexual and sexual stages,
only PfPCNA1 seems to contain all the conserved motifs
for PCNA, including the conserved helix-turn-helix DNA-
binding domain at the N terminus. Moreover, in a phylo-
genetic analysis, PfPCNA1 is grouped with T. gondii
PCNA1 (Li et al., 2002) that has been suggested to be the
major replisomal PCNA using biochemical analysis and
genetic tools (Guerini et al., 2005). Biochemical experi-
ments suggest that PfPCNA1 and PfPCNA2 are part of
the same replisome complex (Patterson et al., 2002).
Therefore, we have considered PfPCNA1 as the marker
for replication foci in P. falciparum and hereafter it will be
termed as PfPCNA.
Using speciﬁc antibodies against PfORC1, PfORC5
and PfPCNA, here we show that PfORC components and
PfPCNA co-immunoprecipitate with each other and they
form distinct colocalized foci following immunoﬂuores-
cence experiments just at the onset of DNA replication in
the early trophozoite stage parasites. As the DNA synthe-
sis progresses, two key changes take place in the
replication factories. PfORC5 and PfPCNA foci slowly
dissociate from each other while PfORC1 is degraded in a
proteasome-mediated pathway- suggesting a regulatory
role of PfORC1 during blood stage parasite development.
We suggest that a putative PCNA-interacting protein motif
(PIP) identiﬁed in PfORC1 and other ORC1 homologues
may facilitate the complex formation among ORC com-
ponents and PCNA during DNA replication. Use of DNA
replication inhibitor hydroxyurea affects parasite growth
and replication foci formation. These results illustrate the
conservation of factory model of replication in Plasmo-
dium and confer a great potential to understand the impor-
tance of ORC proteins for replication foci formation and
progression during S phase in general.
Results
Cloning, amino acid sequence analysis and expression
of putative homologue of PfORC5
Upon BLAST search using full-length as well as C- and
N-terminal regions of yeast and human ORC5 proteins as
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showed ~20% identity and ~43% homology with the yeast
counterpart at the carboxyl-terminal region. Interestingly,
HsORC5p shows ~24% identity (~48% similarity) with
ScORC5p (Quintana et al., 1998) that is comparable
with the homology of PFB0720c C-terminal region with
ScORC5. This ORF has been annotated as conserved
hypothetical protein in PLASMODB although the corre-
sponding homologues in Plasmodium vivax (Pv002750)
and Plasmodium yoelii (PY01116) have been annotated
as putative ORC5 homologues. The average length of
ORC5 in other eukaryotes is between ~430 and 480
residues whereas that of PFB0720c is 899 residues
with an unusual long N-terminal extension containing
two asparagine/aspartic acid/lysine repeat-rich regions
(Fig. S1). This is not unusual feature for Plasmodium pro-
teins as reported earlier (Singh et al., 2004), including the
largest subunit of ORC, PfORC1 that also shows a long
N-terminal extension with asparagines and lysine repeat
residues (Mehra et al., 2005). Excluding the length of the
N-terminal extension region with the repeat sequences,
the length of C-terminal region of PFB0720c is ~440
amino acid residues, within the range of ORC5 proteins in
other species.
Full-length putative PfORC5 gene was ampliﬁed by
polymerase chain reaction using two speciﬁc primers (P1
and P2, Table S1, supplementary information) and 3D7
genomic DNA. Following PCR, a single product (~2.7 kb)
was obtained (as shown in Fig. S2A) that was cloned into
pET28a vector and it was subsequently sequenced using
suitable overlapping primers.
The alignment of amino acid sequence of putative
PfORC5 homologue with S. cerevisiae ORC5 showed
many interesting features (Fig. S1). A putative nucleotide
binding domain (306–310 residues), one of the hallmarks
of the ORC5 proteins, was found between two asparagine
and aspartic acid-rich regions at the N terminus (repeat
regions I and II respectively, Fig. S1). The ORC5 homol-
ogy domain was found at the carboxyl-terminal region
(484–899 residues).Aputative nuclear localization signal-
containing motif was also identiﬁed at the N-terminal
region of PfORC5.
In order to investigate the expression pattern of
PfORC5 during asexual erythrocytic stages, semi-
quantitative RT-PCR analysis was performed using cDNA
isolated from synchronized ring, trophozoite and schizont
stage parasites and speciﬁc primers (P15 and P16,
Table S1, supplementary information) as shown in the
schematic diagram of PfORC5 (Fig. S2B). Total RNA was
treated with DNase I before processing for cDNA prepa-
ration either in the presence or absence of reverse
transcriptase enzyme (+RT and -RT lanes respectively,
Fig. 1A). Comparison of RT products from different eryth-
rocytic developmental stages reveals that the expression
level of PfORC5 goes up several folds during trophozoite
and schizont stages in comparison with ring stage
whereas the control PfGAPDH expression pattern does
not ﬂuctuate to the similar extent during all three stages
(Fig. 1B). PfORC1 and PfMCM4, the other two members
of pre-replication complex (pre-RC) are also expressed
mostly in the trophozoite and schizont stage parasites
similar to PfORC5 expression pattern (all the primers for
RT-PCR analysis are listed in Table S1, P15–P22).
RT-PCR analysis of PfORC5, PfORC1 and PfMCM4 sup-
ports the published microarray data, conﬁrming a peak
of transcription coincident with onset of DNA replication
(Bozdech et al., 2003).
To investigate the expression level of PfORC5 at the
protein level, two polyclonal antibodies were raised in the
rabbit and mouse, respectively, against C-terminal region
of PfORC5 (PfORC5C1 and PfORC5C2 respectively) as
shown in Fig. S2B. Polyclonal antibodies raised in rabbit
predominantly recognized a band around molecular mass
of ~105 kDa following Western blot analysis of parasite
lysate (Fig. 1C). Pre-immune sera under the same experi-
mental conditions do not recognize any such band,
suggesting that these antibodies are speciﬁc against
PfORC5. Polyclonal antibodies raised in mouse also
recognized a similar band in Western blot experiments
(Fig. S2C).
Further, to investigate the subcellular localization of
PfORC5 expression within the parasite, electron micro-
scopic analysis of sections of trophozoite stage parasites
were performed using either rabbit pre-immune sera or
immune sera raised against PfORC5. Analysis of gold
particles deposition within the parasite clearly shows that
PfORC5 is expressed primarily within the nucleus and
not in the cytoplasm or red blood cell (RBC) (Fig. 1D).
Several nuclei were scanned and it was found that the
gold particles were distributed all over the nuclei. On
average, approximately six to eight particles were found in
the trophozoite stage nuclei in each section. Pre-immune
sera under the same experimental conditions do not show
any such gold particle deposition, suggesting the speci-
ﬁcity of these antibodies to detect PfORC5 in the nucleus.
ATP binding, ATPase activity of PfORC5 and functional
complementation in S. cerevisiae
One of the hallmarks of ORC5 is its affinity to ATP
because of the presence of WalkerANTP binding domain
(Bell, 2002). Mutation in the Walker A domain of S. cer-
evisiae ORC5 causes temperature-sensitive growth phe-
notype, suggesting thatATP binding to ORC5 is important
for chromosomal DNAreplication (Takahashi et al., 2004).
In vitro, recombinant ORC containing a mutation in the
ATP binding domain of HsORC5 shows reduced DNA
binding affinity (Giordano-Coltart et al., 2005). PfORC5
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Fig. 1. Expression of PfORC5 at the transcript and protein level and ATP binding/hydrolysis activity of PfORC5.
A. RT-PCR analysis of PfORC1, PfORC5, PfMCM4 and control GAPDH using cDNA obtained from different developmental stages. RT (+) and
RT (-) lanes indicate the PCR products obtained from cDNA prepared either in the presence or absence of reverse transcriptase enzyme
respectively.
B. Fold changes in expression of different genes at different stages. The relative intensity of each band was calculated using densitometry
scanning and the absolute values were calculated by normalizing against background intensity. Each experiment was repeated three times
and the values obtained including the standard deviations were plotted graphically.
C. Western blot analysis to analyse the expression of PfORC5 at the protein level using either anti-PfORC5 or pre-immune sera. Molecular
mass markers are shown on the right.
D. Immunoelectron-microscopic localization of PfORC5 within paraffin-embedded parasite sections using either pre-immune or anti-PfORC5
antibodies respectively. Arrows indicate gold particle depositions and ‘N’ stands for nucleus.
E. Schematic diagram of wild type or different deletion mutants of PfORC5 or full-length S. cerevisiae ORC5. Amino acid co-ordinates were
shown on the right.
F. ATP binding activity of PfORC5. One microgram of the MBP-fused PfORC5D2Wt or PfORC5D2mut proteins were incubated with
[a-
32P]-dATP and was further cross-linked using UV light as described in Experimental procedures. Upper panel shows the SDS-PAGE
analysis of these proteins. The molecular mass markers are shown on the left. The bottom panel shows the autoradiogram of the above gel.
G. ATPase activity of GST-PfORC5D1. ATPase assays were performed either using GST-PfORC5D1 or GST as a control. The positions of the
radiolaelled ATP and the released Pi are marked. The right panel shows the ATPase activity of GST-PfORC5D1 with increasing amount of
protein.
H. Comparison of the ATPase activity of wild type and mutant proteins. ATPase assays were performed using 100 ng of GST-PfORC5D1Wt or
GST-PfORC5D1Mut and phosphate release was quantiﬁed and plotted graphically with standard deviation after repeating the experiments for
three times. The inset shows the puriﬁcation of the wild type and mutant forms of the proteins.
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the protein (306GMGKT310) ﬂanked by repeat regions I and
II (Fig. S1E).
To investigate the ATP binding and ATPase activity of
PfORC5, we have puriﬁed different domains of PfORC5
(Fig. 1E). Unfortunately, we failed to express full-length
PfORC5 because of the presence of asparagines and
aspartic acid repeat regions at the extreme N-terminal
region. However, we have been able to express
PfORC5D1 (excluding the N-terminal repeat regions)
and PfORC5D2 (containing the NTP-binding domain)
(Fig. 1E). First, we investigated the ATP binding property
of PfORC5 using recombinant PfORC5D2 because of its
better yield over PfORC5D1. We also made a mutant form
of the protein by introducing a point mutation at the Walker
Adomain (K toA). Equal amount of wild type and mutated
form of the proteins were incubated with [a-32P] dATP and
subjected to UV cross-linking analysis. Following autora-
diography, wild-type PfORC5D2 was found to be in ATP-
bound form whereas the mutated protein did not bind to
ATP under the same experimental conditions (Fig. 1F).
Although ORC1 has been reported to contain ATPase
activity, no such activity has been attributed to ORC5 yet
(Mehra et al., 2005). This is due to the absence of a clear
WALKER B domain designated as nucleotide hydrolysis
domain in ORC5 homologues from yeast to mammals.
However, there is always a possibility of a cryptic
WALKER B domain present in these proteins. In order to
ﬁnd out whether PfORC5 contains ATPase activity,
release of inorganic phosphate (Pi) from [g-32P] ATP was
monitored in the presence of GST-PfORC5D1o rG S Ta s
a control. The recombinant protein showed ATPase activ-
ity in a concentration-dependent manner whereas the
control GST protein did not show any such activity under
the same experimental conditions (Fig. 1G). A mutant
form of PfORC5D1, containing a point mutation in the
ATP binding domain (K to A within the ‘GMGKT’ NTP
binding motif) showed drastically reduced ATPase activity
when compared with that of wild-type protein (Fig. 1H).
The residual activity in PfORC5D1Mut could be due to
the presence of some minor ATPase contaminant in the
protein preparation. Identiﬁcation of WALKER B NTP
hydrolysis domain in PfORC5 will be helpful to ascertain
the ATPase activity of PfORC5.
To further prove that the putative PfORC5 is a true
ORC5 homologue, we performed functional complemen-
tation in yeast using either full-length or deletion mutant of
PfORC5 or chimera constructs of ScORC5 and PfORC5
fusing N- and C-terminal of these respective proteins. We
adopted the chimera approach because of the presence
of two repeat regions (I and II respectively, Figs S1 and
2A) at the N terminus of PfORC5 that may affect the
expression of full-length PfORC5 in yeast. We decided to
fuse the N-terminal region of ScORC5 containing NTP
binding domain with the C-terminal homology region of
PfORC5 (Fig. 2A). While doing the same, we also consid-
ered the secondary structure of both PfORC5 and
ScORC5 so that we do not delete helix or beta sheet
regions of these proteins. We used the overlapping PCR
method to construct the chimeras (Horton et al., 1989).
This method allowed us to fuse ScORC5DC (1–184)
and PfORC5DN2 (561–899) to get Chimera ORC5
(ScORC5DC + PfORC5DN2). The strategy for making the
chimera is shown in schematic diagrams (Fig. 2A and B)
and the detailed methods are described in supplementary
data (Experimental procedures section, complementation
of yeast ORC5 mutant strain). An ORC5 mutant haploid
strain of S. cerevisiae (ySPB5.11, with S. cerevisiae W303
background, a kind gift from Dr Steve Bell, MIT, USA) with
a deletion of chromosomal copy of ORC5 and having
wild-type ORC5 gene in a plasmid containing ura3 marker
was used for complementation studies. This yeast strain
was transformed with plasmid constructs containing
either full-length PfORC5 or ScORC5 or PfORC5DN1
(172–899 aa) or the chimera construct, or N-terminal and
C-terminal domains of ScORC5 and PfORC5 alone
respectively, or pRS314 empty vector alone under
galactose-inducible promoter with a tryptophan marker.
Following transformation, the transformants were grown
either in the absence or presence of 5-ﬂuoroorotic acid for
the selection of viable yeast cells in minimal media without
tryptophan. We ﬁnd that full-length ScORC5 complements
this mutant yeast strain in the presence of 5-FOAwhereas
full-length PfORC5 and PfORC5DN1 cannot rescue these
cells under the same experimental conditions (Fig. 2C).
Interestingly, the chimera containing N terminus of
ScORC5 and C terminus of PfORC5 complements these
cells whereas only N-terminal region of ScORC5 or only
C-terminal region of PfORC5 or the empty vector pRS314
cannot rescue these cells (Fig. 2C). The inability of
PfORC5 to complement the yeast mutant strain is due to
the presence of repeat regions at the N terminus affecting
the expression of full-length protein or PfORC5DN1 in
yeast. It was further conﬁrmed by Western blot analysis
using the lysate obtained from yeast cells containing
either wild-type PfORC5 or PfORC5DN1 or chimera
constructs. Anti-PfORC5 antibodies speciﬁcally recog-
nized a band in chimera lane only with a molecular
mass of ~70 kDa (consistent with the molecular mass
of chimera construct) (upper panel, Fig. 2D). The
coomassie-stained gel conﬁrms the presence of equal
amount of protein in all the lanes (lower panel, Fig. 2D).
The presence of C-terminal ORC5 homology region in
PFB0720c, the conserved and functional ATP binding
domain at the N terminus of PFB0720c and the ability of
the chimera construct to functionally complement
ScORC5 mutant yeast strain clearly suggest that the
putative PfORC5 is a true homologue of ORC5.
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Fig. 2. Complementation of PfORC5 in S. cerevisiae.
A. Schematic diagrams of PfORC5 and ScORC5. The repeat regions (I and II) and NTP binding domains are shown as open boxes whereas
the ﬁlled box shows the C-terminal ScORC5 homology region. The grey box in ScORC5 shows the N-terminal region containing NTP binding
domain. Both PfORC5 and ScORC5 can be divided into two parts (I and II) respectively.
B. The schematic diagrams show different regions of PfORC5 and ScORC5 or the chimera containing N terminus of ScORC5 and C terminus
of PfORC5 as used for complementation assay. The rationale for chimera construction has been described in Results section and
supplementary method section.
C. A swapper strain of S. cerevisiae ORC5 with the deletion of chromosomal copy of ScORC5 gene and maintaining the same gene with a
plasmid containing ura marker was transformed with either wild-type or different chimeras of PfORC5 and ScORC5 (with trp selection) either
in the presence or absence of 5-ﬂuoroorotic acid. Growth of these transformants was followed by spot test using serial dilutions.
D. Western blot analysis to show the expression of different constructs as used in the complementation assay. Anti-PfORC5 polyclonal
antibodies were used for Western blot analysis. The coomassie-stained gel following protein transfer on PVDF membrane is shown as loading
control. * indicates the expression of chimera protein in yeast. The molecular mass marker is shown on the right.
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intraerythrocytic developmental stages
In an effort to investigate subcellular localization and the
pattern of PfORC5 expression during intraerythrocytic
developmental stages, we performed thorough immunof-
luorescence analysis at different time points in a synchro-
nized parasite population using immuno-affinity-puriﬁed
anti-PfORC5 antibodies. We also used anti-PfPCNA anti-
bodies to locate the active replication foci in these cells as
PCNA has been widely used as a marker for growing
replication forks (Leonhardt et al., 2000; Meister et al.,
2007).
Analysisofimmunoﬂuorescenceimagesatdifferenttime
points revealed the presence of PfORC5 at the ring and
early trophozoite phase parasites with a diffused staining
pattern. Interestingly, PfORC5 forms distinct foci within
nuclei as the parasites mature further (mid-trophozoite
phase parasites) (Fig. 3A). The size and the number of
such foci increase as the parasites undergo further matu-
ration until late schizont stage where the average size of
such foci decreases compared with those found in mid-
trophozoite and early schizont stages. When the same
parasiteswerescreenedforPCNA(replicationfocimarker)
signals, it showed somewhat diffused pattern during early
trophozoitestagelikePfORC5.Astheparasitesdeveloped
further into mid-trophozoite stages, PfPCNA showed dis-
tinct foci as PfORC5 and these dots mostly merged with
PfORC5 dots as seen from the merged panels (Fig. 3A,
panel 3). The number and average size of the PCNA foci
also increased till mid-schizont stages and both these
parameters decreased at the late schizont stages.
Although the PfORC5 and PfPCNA foci merged mostly
with each other at these stages, these foci slowly dissoci-
ated from each other as the parasites developed further
and the majority of these spots separated from each other
at the late schizont stage (Fig. 3A, panel 7). Please see
enlarged and high-resolution Fig. S3A for the expression
pattern of these proteins at late schizont stage. In a control
setofexperiments,noneofthepre-immuneserashowany
immunoﬂuorescence signal under the same experimental
conditions, conﬁrming the speciﬁcity of these antibodies
(Fig. 3B).
It will be interesting to see whether the replication foci
formation and progression are correlated with the extent
of DNA replication through intra-erythrocytic development
cycle. Additionally, the immunoﬂuorescence studies pre-
sented here are based on the slides containing parasite
smears that have been ﬁxed using acetone-methanol ﬁxa-
tion method (please see the Experimental procedures
section for details). The slides were washed very exten-
sively during immunoﬂuorescence assay (IFA) to avoid
any background staining. Although this method gives
us distinct pattern of replication foci formation,
the DAPI (9,6-diaminido-2-phenylindole) shows diffused
staining pattern. In order to avoid any bias that may arise
because of a particular method of ﬁxation, we repeated
the IFAusing synchronized parasites that were ﬁxed using
paraformaldehyde (PFA). For this purpose, we synchro-
nized the 3D7 parasites at the ring stage and the same
was divided into four aliquots and they were allowed to
grow further. The growth of the parasites was monitored
time to time. The parasites were harvested at ring, tropho-
zoite, early schizont and late schizont stages. The glass
slides were made to conﬁrm their stages by giemsa stain-
ing (Fig. S4A) and they were ﬁxed with PFA and pre-
served for further IFA analysis. Total genomic DNA was
isolated in each case and they were analysed by agarose
gel electrophoresis (Fig. S4B). The total DNA was further
quantiﬁed spectrophotometrically and plotted accordingly
(Fig. S4C). We ﬁnd that as the parasites grow, the total
DNA content increases many folds from ring to schizont
stages, reﬂecting a huge amount of concomitant DNA
replication with growth progression.
Further analysis of the parasites obtained from the
same stages as described above following IFA experi-
ments using anti-PfORC5 and anti-PfPCNA antibodies
suggests a similar pattern of replication foci formation
and progression during development. Both PfPCNA and
PfORC5 formed colocalized distinct foci during early-to-
mid replicating trophozoite stages. These foci started
dissociating from each other with further growth progres-
sion and ﬁnally they separated completely during late
schizont stage as shown earlier (Fig. S5). The average
number of PfPCNA or PfORC5 foci or the colocalized
foci and their pattern were found to be similar as
Fig. 3. Colocalization and interaction between PfORC5 and PfPCNA.
A. Immunoﬂuorescence assay to show colocalization of PfORC5 and PfPCNA as replication foci marker. Glass slides containing thin smears
of P. falciparum-infected erythrocytes from the different erythrocytic stages were incubated with affinity-puriﬁed rabbit anti-PfORC5 and mouse
anti-PfPCNA antibodies followed by respective secondary antibodies. Merged 1 panel shows the merged images of nuclear DAPI, green
PfORC5 staining and red PfPCNA staining whereas merged 2 panel shows the merged images of green PfORC5 and red PfPCNA signals
only. The bar as shown in the inset is equivalent to 3 mm.
B. Immunoﬂuorescence assay under the same experimental conditions as shown in A using pre-immune sera against respective antibodies.
C. Co-immunoprecipitation of PfORC5 and PfPCNA from parasite extract obtained from synchronized parasite pellet collected from either
trophozoite or late schizont stage parasites. The extracts were ﬁrst immunoprecipitated (IP) with anti-PfORC5 antibodies followed by
immunoblotting (IB) with either anti-PfORC5 (top panel) or anti-PfPCNA (bottom panel) antibodies. The input lanes show the presence of
these proteins in both the stages. Arrowhead indicates the position of the respective proteins. Molecular mass markers are shown on the right.
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acetone ﬁxation method.
Although ORC components colocalize with PCNA
during S phase to a limited extent in mammalian cells
(Prasanth et al., 2004), no biochemical evidence is avail-
able yet to prove that these proteins are truly the compo-
nents of replication foci.
To verify whether ORC components and PCNAare truly
the members of replication factories, we performed immu-
noprecipitation reactions using parasite extracts and anti-
bodies against PfORC5 and PfPCNA. Both PfPCNA and
PfORC5 can be immunoprecipitated from mixed tropho-
zoite stage parasite extract using immune sera but not
with pre-immune sera (Fig. S3B). To ﬁnd out whether
these proteins co-immunoprecipitate with each other, we
ﬁrst immnuprecipitated PfORC5 from the parasite extract
derived from either mixed stage trophozoites or late
schizont stage parasites followed by immunoblotting
using anti-PfORC5 or anti-PfPCNA antibodies respec-
tively (Fig. 3C, top and bottom panels). We found that
PfORC5 was immunoprecipitated from both trophozoite
and schizont stages (Fig. 3C, top panel). Interestingly, we
observed that PfPCNA was co-immunoprecipitated with
PfORC5 during trophozoite stage only but not at the late
schizont stage. PfPCNA was expressed at both the
stages to the similar extent as shown by the input lanes
(Fig. 3C, bottom panel). These results conﬁrm the colo-
calization of PfORC5 and PfPCNA during trophozoite
stages but not at the schizont stages.
PfORC1, another member of the ORC colocalizes
with PfORC5 and PfPCNA but gets degraded at
the late schizont stage
Although ORC functions collectively as a replication ini-
tiator protein, different components of ORC are regulated
differentially in a cell cycle manner. The level of ORC2–5
does not change through cell cycle whereas ORC1 comes
on and off the chromatin in a cell cycle-regulated manner
in mammalian cells (Méndez et al., 2002). In hamster
cells, ORC1 is dissociated from chromatin as cells enter S
phase, transformed into a mono- or diubiquitinated form,
followed by deubiquitination and re-binding to chromatin
during the M-to-G1 transition (Li and DePamphilis,
2002). To investigate the fate of PfORC1 during different
developmental stages, we performed immunoﬂuores-
cence experiments as shown in Fig. 4A using rabbit
anti-PfORC5 and mouse anti-PfORC1 antibodies
simultaneously. PfORC5 showed same pattern of foci
formation and progression as shown earlier (Fig. 3A).
PfORC1 was not detected in ring stage parasites followed
by a diffused pattern in early trophozoite parasites. During
mid-trophozoite stages, PfORC1 also showed multiple
foci that mostly merged with PfORC5 foci (Fig. 4A, panel
3). These merged patterns continued till mid-schizont
stages until PfORC1 signal was completely diminished in
the late stage parasites (Fig. 4A, last two panels). These
results indicate that PfORC1 is degraded at the late sch-
izont stage parasites whereas PfORC5 still persists in a
different compartment than PCNA.
To revalidate immunoﬂuorescence data, we performed
Western blot analysis using parasite extract derived from
synchronized parasites either from mixed stage tropho-
zoites or late stage schizonts. Western blot analysis
detected the presence of PfORC1 in trophozoite stage but
not in the late schizont stage whereas both PfORC5 and
PfPCNA were present at both the stages (Fig. 4B).
Coomassie-stained membrane following Western blot
shows that the loading of proteins was comparable in both
the lanes (Fig. 4B, second panel). These results strongly
suggest that different ORC components are regulated
differentially during development.
We further investigated colocalization pattern
of PfORC1–PfPCNA during development. Co-
immunoﬂuorescence analysis using anti-PfORC1 and
anti-PfPCNA antibodies showed that the majority of the
ORC1 and PCNA foci merged with each other during
trophozoite stages (Fig. 4C, panels 2 and 3). ORC1 signal
was completely abolished during late schizont stages
whereas PCNA foci could still be found during this stage
(Fig. 4C, last panel).
Identiﬁcation of putative PIP motif in PfORC1
We have found most strikingly the complete colocalization
of replication foci marker PCNA and ORC components at
the onset of DNAreplication. So far, attempts to colocalize
these proteins completely in S phase have failed in yeast
Fig. 4. Colocalization pattern of PfORC5 and PfORC1 during different erythrocytic stages.
A. Immunoﬂuorescence assay to show expression pattern of PfORC5 and PfORC1 during different development stages. Affinity-puriﬁed rabbit
anti-PfORC5 and mouse anti-PfORC1 antibodies were used as primary antibodies followed by respective secondary antibodies. Merged 1
panel shows the merged images of nuclear DAPI, green PfORC5 and red PfORC1 signals whereas merged 2 panel shows the merged
images of green PfORC5 and red PfORC1 signals. The bar is equivalent to 3 mm.
B. Western blot analysis to compare the expression of various replication initiation proteins during trophozoite and late schizont stages.
Equivalent amount of parasite pellet obtained from the above two stages were boiled in SDS-PAGE loading buffer followed by Western blot
analysis using either anti-PfORC1 or anti-PfPCNA or anti-PfORC5 antibodies. Molecular mass markers are shown on the right. The membrane
following Western blot was coomassie-stained to show the loading control.
C. Colocalization pattern of PfORC1 and PfPCNA during parasite development. Immunoﬂuorescence assay was performed as described
earlier using rabbit anti-PfORC1 and mouse anti-PfPCNA antibodies. The bar as shown in the inset is equivalent to 3 mm.
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these proteins are part of the replication factory by
co-immunoprecipitation experiments. PCNAinteracts with
its several partners (e.g. Fen1, p21, CDT1, MCM10, DNA
ligase, etc.) through a conserved PIP motif present in
these proteins (Arias and Walter, 2006; Das-Bradoo et al.,
2006; Moldovan et al., 2007). We were curious to know
whether PfORC components would contain such PIP box
that would justify the colocalization of these proteins in
replication foci. Surprisingly, we have identiﬁed a close
match to the conserved PIP motif, QXX(M/L/I)XX(F/
Y)(F/Y) in PfORC1 (Fig. 5A). Interestingly, we have also
identiﬁed PIP motif both in human and yeast ORC1, sug-
gesting that this domain might play a fundamental role in
eukaryotic DNA replication. We further performed direct
pull-down experiments using maltose-binding protein
(MBP) beads fused to PfORC1C (C terminus of PfORC1
with PIP motif) or PfORC1C1 (C terminus of PfORC1
without PIP motif) or MBP alone along with soluble recom-
binant puriﬁed PfPCNA. Following pull-down experiments
and Western blot analysis with anti-PfPCNA antibodies,
we found that PCNAinteracted speciﬁcally with PfORC1C
with PIP motif but not with PfORC1C1 without PIP motif or
MBP alone under the same experimental conditions
(Fig. 5B and C). Together with in vivo colocalization and
co-immunoprecipitation data, these in vitro pull-down
experiments suggest that ORC may facilitate the recruit-
ment of PCNA to the replication fork and it may reﬂect a
general mechanism for eukaryotes as PIP motifs are con-
served in ORC1 from yeast to mammals.
Replication foci formation and progression during
P. falciparum erythrocytic developmental stages
in relation to DNA replication
We have already established the correlation between
DNA replication and replication foci formation (Fig. S4). It
will be interesting to see whether formation and propaga-
tion of these nuclear foci during development are related
to the rate and timing of DNA replication in the parasites.
Several groups have reported the timing and duration of
DNA replication in synchronized parasite culture using
radioactive nucleotide in the absence or presence of DNA
replication inhibitors like hydroxyurea or proteasome
inhibitors (Inselburg and Banyal, 1984; Arnot and Gull,
1998; Gantt et al., 1998). Based on these results, it is
understood that DNA replication initiates after ~22–24 h
following invasion, peaks at ~30–32 h, decreases there-
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Fig. 5. Identiﬁcation of conserved PIP motif in ORC1.
A. The consensus PIP motif is shown on the top. The putative PIP domains present in ScORC1, PfORC1 and HsORC1 are also shown. The
conserved residues are marked in bold.
B. The schematic diagrams of C-terminal region of PfORC1 with (PfORC1C) or without (PfORC1C1) PIP domain fused to MBP. The residues
of PfORC1 taken in each construct are also shown. The PIP motif is marked as black box.
C. Pull-down experiments using MBP-fused ORC1 constructs. Two microgram of His6-PCNA was incubated with equal amount of MBP beads
containing MBP-ORC1C (+PIP motif) or MBP-ORC1C1 (-PIP motif) or MBP alone followed by stringent washing of the beads using buffer as
mentioned in the Experimental procedures. The bound proteins were released by boiling in SDS-PAGE loading buffer followed by Western blot
analysis using anti-PfPCNA antibodies. The input lane shows 0.5% PCNA. The bottom panel shows the loading control for pull-down
experiments with MBP alone or other fusion proteins.
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pattern is shown in Fig. S6Abased on the results obtained
from various studies.
In order to ﬁnd out whether replication pattern coincides
with foci formation pattern, we calculated the number of
foci formed at each stage during development for ORC1,
ORC5 and PCNA. Number of colocalized foci for ORC5–
PCNA and ORC1–ORC5 were also counted. We used
acetone-methanol ﬁxation method as it gave us more
distinct and slightly higher number of replication foci prob-
ably because of the better access of the antibodies to the
proteins. Several parasites (more than 100 in each case)
from multiple slides were scanned at each developmental
stage to rule out the possibility of any bias for the stage of
the parasites and number of foci found in each stage.
Graphical representation of these results indicates that
overall pattern of the foci formation strongly correlates
with the DNAreplication pattern. Comparison of individual
PCNAand ORC5 foci formation reveals that foci formation
starts during early-to-mid trophozoite stage for both of
them (Fig. S6B). The number of foci further increases
with further development, reaching the maximum number
during mid-to-late trophozoite stages where DNA replica-
tion also peaks. Number of ORC5 foci do not change
drastically thereafter whereas the number of PCNA foci
drops at the late schizont stage. It is possible that the
increase in replication foci per parasite at later stages is
due to the increase in genome content or number of nuclei
following each round of replication.
Analysis of PCNA–ORC5 merged foci clearly indicates
that the formation and progression of such merged foci
also follows the DNA replication pattern (Fig. S6C). The
numberofmergedfocipeaksduringmid-trophozoitestage
withavalueof~15perparasite,suggestingthepresenceof
these many active replication foci containing both PfPCNA
and PfORC proteins during peak replication phase. The
numbers decline drastically thereafter with very little asso-
ciation with each other during late schizont stage. ORC1–
ORC5 merged foci also follow the same pattern with the
maximum number of merged foci visible during mid-
trophozoite stages followed by reduction of these numbers
at the following stages until late schizont stages where
ORC1 foci were completely abolished (Fig. S6D).
It is important to note that the formation, progression
and colocalization of PfORC and PfPCNA foci strongly
complement biochemical co-immunoprecipitation data to
reconﬁrm our conclusions. The actual number of replica-
tion foci per nucleus in the infected parasite may vary as
the replication foci number counting is based on the visual
inspection of IFA analysis of the different ﬁxed parasites
at different time points. Further live cell imaging using
transgenic ﬂuorescent parasite line expressing PfORC or
PfPCNA fusion protein will be required for quantitative
analysis of replication foci formation and progression.
Perturbation of parasite growth with the intervention of
inhibitors affects replication foci formation
To investigate further whether PfORC and PfPCNA foci
are true representation of replication foci, we used DNA
replication inhibitor hydroxyurea that blocks the elonga-
tion of DNA replication fork by depleting the pool of
nucleotides (Thelander and Reichard, 1979). It has been
reported earlier that the addition of hydroxyurea
(~60 mgm l -1 or more) in synchronized ring stage parasites
arrests them in early trophozoite stage corresponding to
the time of initiation of DNA synthesis (Inselburg and
Banyal, 1984). Accordingly, P. falciparum 3D7 parasites
were synchronized at the ring stage and parasites were
grown either in the absence or presence of hydroxyurea
(~70 mgm l -1). Analysis of the morphology of the parasites
following Giemsa staining after ~32 h of drug treatment
(Fig. S7A) shows that they are blocked at the trophozoite
stage as reported earlier (Inselburg and Banyal, 1984)
whereas the untreated parasites grow normally. Immun-
oﬂuorescence assay using anti-PfORC5 and anti-
PfPCNA antibodies show normal progression of foci
formation and propagation in the absence of drugs. Incu-
bation of the parasites in the presence of drugs (~32 h,
post treatment) results in reduced and fragmented nuclei
compared with the control parasites as shown in DAPI
stained parasites (Fig. 6A, panels 3 and 6 respectively).
Interestingly, the majority of the parasites (~85–90%)
showed diffused staining pattern for both ORC5 and
PCNA following ~22 h and ~32 h of drug treatment com-
pared with the distinct foci containing parasites present in
the untreated culture. Finally, Western blot analysis using
anti-PfPCNA and anti-PfORC5 antibodies against para-
site lysate obtained from drug-treated and untreated
samples revealed the presence of ORC5 and PCNA both
in the absence and presence of drug although they failed
to form distinct foci in the majority of the parasites follow-
ing hydroxyurea (HU) treatment at higher concentration
(Fig. 6B).
The mode of action of HU has been reported to be the
depletion of the pool of dNTPs by inhibiting ribonucleotide
reductase and it should not affect the loading of pre-RC
components like ORC. The absence of ORC5 foci forma-
tion in the presence of ~70 mgm l -1 HU was a bit surprising
to us. Therefore, to address this issue thoroughly, we used
differentconcentrationofHU(0,20,40and70 mgm l -1)and
followed the formation of replication foci at different time
points by immunoﬂuorescence assay (Fig. S8A). The
averagenumberoffociperRBC-infectedparasitewasalso
calculated (~100 RBC-infected parasites were counted at
each HU concentration at two different time points, 22 h
and 60 h post treatment respectively) and plotted accord-
ingly (Fig. S8B). We ﬁnd that following ~22 h of drug treat-
ment, increasing concentration of HU affects ORC5 foci
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effect at 20 mgm l -1 HU concentration, moderate effect at
40 mgm l -1 drug concentration and maximum effect at the
highest drug concentration (70 mgm l -1) (Fig. S8A and B).
This effect was more prominent following ~60 h following
drug treatment (the next cycle) where ORC5 foci formation
was further decreased (Fig. S8B) even in the lower con-
centration of drugs (20–40 mgm l -1). HU-treated parasites
were able to re-invade fresh RBCs at lower concentration
(20–40 mgm l -1) as evidenced with the increase in para-
sitemia during second cycle compared with that of
70 mgm l -1 HU-treated parasites (data not shown).
It is possible that HU treatment may activate check-
point in the parasites, leading to the stall of DNA repli-
cation, decrease in average number of replication foci
and growth arrest as shown in other eukaryotes
(reviewed in Nyberg et al., 2002). At higher drug concen-
tration (70 mgm l -1), it may cause a very drastic and
immediate effect on replication foci formation and growth
arrest. In order to test the hypothesis whether a check-
point is activated in HU-treated parasites, we incubated
HU-treated parasites in the absence or presence of
caffeine. Caffeine can override both S-M and G2-M DNA
damage checkpoints (Moser et al., 2000). We ﬁnd that
addition of caffeine (100 mgm l -1) in HU-treated culture
(70 mgm l -1) increases the ORC5 foci containing para-
sites two to three times compared with the HU-treated
culture only (Fig. S8C). The re-appearance of foci in
some parasites was truly reﬂected in parasitic growth to
some extent. The parasitemia of only HU-treated para-
sites did not alter after 50 h post drug treatment (next
cycle) whereas caffeine-treated parasites (in the pres-
ence of HU) showed greater than twofold increase in
parasitemia (Fig. S8D). These results support our
hypothesis of activation of checkpoint in the parasites in
the presence of HU, leading to the inhibition of DNA
replication and parasitic growth.
To further investigate the mechanism of disappearance
of PfORC1 at the late schizont stage, we added different
concentrationofMG132(100 nM,1 mMand10 mMrespec-
tively), an inhibitor of proteasomal degradation pathway
after ~40 h post invasion in the synchronized parasite
culture.Analysis of the morphology of the parasites follow-
ing drug treatment reveal slower growth of the parasites
following 100 nM drug treatment compared with the
untreated parasites whereas higher concentrations of
drugs inhibit parasite growth completely with immediate
effect (Fig. S7B). Immunoﬂuorescence assays were per-
formed using anti-PfORC1 antibodies using parasites
derived from 100 nM drug-treated and untreated culture
after 8 h following the addition of drug.The results indicate
that PfORC1 signal can be detected in the untreated
parasitesbeforetheadditionofMG132.However,PfORC1
signal is completely abolished in the same untreated
samples following 8 h at the late schizont stage whereas
PfORC1 foci can still be visible in the drug-treated para-
sites, suggesting that MG132 can protect PfORC1 from
getting degraded at late schizont stage (Fig. 6C).
Further, we performed Western blot analysis using anti-
PfORC1 antibodies against parasite lysate derived from
untreated and drug-treated samples. Untreated samples
(~48 h) do not show any band corresponding to ORC1,
suggesting that ORC1 is degraded at the late schizont
stage (Fig. 6D). Parasite lysate derived from samples
before drug treatment (~40 h) clearly shows a band
corresponding to PfORC1. Interestingly, drug-treated
samples (~48 h) shows a band corresponding to ORC1
that is shifted upward compared with the position of ORC1
band in the ‘40 h’ time point lane, suggesting that treat-
ment of MG132 prevents degradation of PfORC1 that
might have undergone some post-translational modiﬁca-
tion during late schizont stage. As a control, Western blot
experiments using anti-PfPCNA antibodies show the
presence PfPCNA in both in MG132-treated sample and
in control sample.
Discussion
The putative PfORC5 homologue shows ~20% identity
and ~43% homology with ScORC5 at the C-terminal
region. The presence of functional NTP binding domain
(hallmark of ORC5 proteins), ability to complement a
Fig. 6. Effects of inhibitors on replication foci formation.
A. Effects of hydroxyurea on PfPCNA and PfORC5 foci formation. Synchronized ring stage parasites were grown either in the presence or
absence of hyroxyurea (70 mgm l
-1) and parasites were harvested at different time points (as shown on the right) for immunoﬂuorescence
assay using anti-PfORC5 and anti-PfPCNA antibodies followed by respective secondary antibodies. The bar as shown in the inset is
equivalent to 3 mm.
B. Western blot analysis using anti-PfPCNA and anti-PfORC5 antibodies using parasite pellet before and after drug treatment.
C. Effect of proteasome inhibitor MG132 on PfORC1 expression. Synchronized parasite cultures at early-to-mid schizont stages (~40 h
following synchronization) were incubated either in the absence or presence of 100 nM MG132 for 7–8 h until the untreated parasites reach
late schizont stage. Glass slides were made using parasites obtained from control and drug-treated culture followed by immunoﬂuorescence
assay using anti-PfORC1 antibodies and ALEXA ﬂuor 488 conjugated secondary antibodies.
D. Top panel shows the Western blot analysis using anti-ORC1 antibodies against the parasite pellet obtained from the same samples as
shown in Fig. 6C. MG132-treated parasites showed the presence of a shifted band (*) at the late schizont stage. The bottom panel shows the
Western blot analysis using anti-PfPCNA antibodies as used in the upper panel.
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with ORC1 and PCNA during DNA replication suggest
that it is the best candidate for ORC5 homologue in
P. falciparum.
Apart from PfORC1 and PfORC5, only a putative
homologue of ORC2 has been identiﬁed in P. falciparum
genome, suggesting that either PfORC contains limited
number of subunits or it contains functional homologues
of other subunits.
We propose the following model for the regulation of
DNA replication in P. falciparum (Fig. 7). Following
schizogony, the newly released merozoites invade new
erythrocytes to initiate the ring stage (G1 phase). PfORC1
is not present at the protein level during early ring stages
but gets expressed during late ring/early trophozoite
stage parasites (Fig. 4A). ORC5 and PCNAare present at
the late ring/early trophozoite stage parasites (Fig. 3A).
As the parasites mature further, these proteins form dis-
tinct colocalized replication foci. ORC1 with putative PIP
motif may facilitate the recruitment of PCNA. These
replication foci remain intact during the period of DNA
replication (S phase) and slowly the proteins forming the
replication foci follow different pathways. ORC1 gets
degraded during the late schizont stage parasites, while
PCNAand ORC5 separate from each other during the late
schizont stage ensuring no further DNA replication at this
stage. The post-DNA replication stage that includes chro-
mosome segregation, formation of daughter nuclei and
cytokinesis leading to the production of new merozoites is
considered to be the G2/M phase. This model proposes
co-ordinated processing of clustered replication forks
(replication factory model) during S phase progression in
the parasites and sheds light into our understanding of
complex mechanism of DNA replication initiation and pro-
gression in P. falciparum.
We have identiﬁed putative cyclin-cdk phosphorylation
sites (SPTK and TPKK respectively) at the N terminus of
PfORC1. These putative cdk-phosphorylation sites might
undergo phosphorylation followed by ubiquitination-
mediated degradation of PfORC1. This is similar to the
fate of human ORC1 that is expressed and targeted
to chromatin as cells exit mitosis and pre-replicative
complexes are assembled. As the cells enter S phase,
HsORC1 probably gets phosphorylated in cyclin
A-dependent manner followed by ubiquitination and deg-
radation in a proteasome-mediated pathway (Méndez
et al., 2002). In hamster cells, ORC1 has been reported to
be ubiquitinated following release from the chromatin as
the cells enters S phase (Li and DePamphilis, 2002). The
post-translational modiﬁcation of HsORC1 and its subse-
quent degradation at the late schizont stage clearly
suggest that PfORC1 is similarly modiﬁed and perform
regulatory role in Plasmodium DNA replication as
described above for other species.
The immunocolocalization and co-immunoprecipitation
of ORC components and PCNA during DNA replication,
the presence of putative PIP domain in PfORC1 and the in
vitro pull-down experiments with PfORC1 and PCNA are
also important and novel ﬁndings. These results clearly
suggest that ORC and PCNA are the active components
Fig. 7. Model of replication foci formation
and progression in P. falciparum. P. falciparum
ORC may contain fewer subunits than other
eukaryotes with conﬁrmed PfORC1, PfORC5
and a putative PfORC2 subunit. During
intraerythrocytic developmental cycle (IDC),
different proteins are regulated differently.
Based on our immunoﬂuorescence and
Western blot data and other published data,
PfORC1 is expressed during late ring or early
trophozoite stage whereas both PfPCNA1 and
PfORC5 are present through all stages. At the
onset of DNA replication, during early
trophozoite stage, these proteins colocalize
with each other and form replication foci.
These foci continue to replicate nuclear DNA
till late trophozoite/early schizont stage.
During schizont stage, these proteins follow
different pathways. PfORC5 and PfPCNA
slowly detach from each other until late
schizont stage where the majority of these
foci are separated from each other. However,
PfORC1 is completely degraded at this late
schizont stage. G1, S and G2/M phases are
also indicated according to parasitic
developmental stages. Free Merozoites
ORC5
PCNA
Replication 
Foci
ORC1 degradation
Ring (G1)
0 to ~16/18 h
Trophozoite (S)
~18 to ~ 34 h
Schizont (G2: M)
~34 to ~48 h
DNA synthesis
~24h
~34h IDC
X
ORC1 with 
putative PIP 
ORC1
Replication 
foci
ORC5 and PCNA 
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1 5
2
3,4,6??
Hydroxyurea
Invading new 
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ScORC1 and HsORC1 homologues may suggest its con-
served role during eukaryotic DNA replication. ORC1 with
the putative PIP box may facilitate loading of PCNA at the
replication fork. Recently, a similar function has been pro-
posed for MCM10 (Das-Bradoo et al., 2006).Alternatively,
it may be suggested that ORC components are not only
the part of the pre-RC, they are also active components
of the growing replication fork where the putative PIP
domain in ORC1 plays a major role to hold these proteins
together along with PCNA. The degradation of PfORC1 at
the later stage with the concomitant separation of ORC
and PCNA foci strengthens the above hypothesis. The
separation of PCNA from ORC binding sites can also be
attributed to the differential affinity of PCNA towards dif-
ferent proteins during development. In fact, it has been
reported earlier that binding of PCNA to its different part-
ners is modulated by different modiﬁcations of PCNA, like
ubiquitination and sumoylation that help to attract speciﬁc
binding partners like translesion polymerases and Srs2
helicase respectively, because of the presence of speciﬁc
binding motifs in these proteins during bypass DNA rep-
lication following DNA lesions (Kannouche et al., 2004;
Papouli et al., 2005).
Presence of PfPCNAduring the late schizont stage may
be required for genome maintenance processes dealing
with stalled replication forks, such as translesion synthe-
sis as reported in mammalian cells (Essers et al., 2005;
Moldovan et al., 2007). Additionally, accumulated PCNA
on DNA at late stages might recruit some replication
factors like Cdt1 that is ubiquitinated by DDB1-Cul4 ubiq-
uitin ligase following interaction with PCNA, thereby clear-
ing the nucleus from Cdt1-mediated licensing activity
(Arias and Walter, 2006).
Presence of PfORC5 at the late stage may ensure its
availability for the next cycle of DNA replication. Alterna-
tively, as ORC components have been shown to be
essential for silencing Hidden MAT left and Hidden MAT
right mating-type loci in S. cerevisiae, PfORC5 may follow
similar suits in gene silencing particularly in var gene
silencing that needs to be explored further.
In mammalian cells, the organization of replication fac-
tories is dependent on chromatin architecture and struc-
ture of chromosomal domains that are dictated by nuclear
matrix. The presence of histones, chromatin-modifying
enzymes (histone acetylases and deacetylases) and
nuclear matrix protein coding genes in Plasmodium
genome suggests that chromatin structure will also play
critical role in deciding the fate of the replication foci.
In mammalian cells, ~10 000 replication sites with an
average 1 mbp of DNA per replication site account for
chromosomal DNA replication during S phase with
approximately six replicons per replication site (Ma et al.,
1998). In contrast, we ﬁnd average ~15 colocalized
(PfORC and PfPCNA) replication foci in Plasmodium
during the peak of DNA replication. Considering that the
Plasmodium genome size is ~24 mbp, each replication
foci can account for replication of ~1.5 mbp DNA, a value
close to the other eukaryotes. It is interesting to note that
the replication rate is faster in Plasmodium than in higher
eukaryotes. Plasmodium genome content increases from
1 N to 16 to 32 N within a span of 12–16 h, whereas
mammalian nuclear DNA replicates only once during
the same time period. Therefore, the replication foci in
Plasmodium must contain higher number of replicons
compared with that of mammals. It is possible that origin
frequency in Plasmodium is much higher than in eukary-
otes, accounting for the higher number of replicons per
foci. This may also explain the distinct colocalization of
PCNA and ORC in Plasmodium that is not common in
higher eukaryotes.
The gradual disappearance of ORC5 foci in the pres-
ence of increasing concentration of HU is very surprising.
In general, HU depletes the pool of dNTPs and it should
not affect the loading of pre-RC components. We believe
that increasing concentration of HU has a direct effect on
depleting the dNTP pool that may affect the foci formation
at later time points. P. falciparum undergoes multiple
rounds of DNA replication. Depletion of dNTP pools may
affect severely the late rounds of DNA replication. Addi-
tionally, the foci that are formed initially may diffuse with
time. This may explain the gradual decrease of foci for-
mation with increasing drug concentration. This is in
consistence with the ﬁnding reported by Santocanale and
Diffley (1998) that suggests speciﬁc prevention of late-S
origins in the presence of HU. Higher concentration of HU
(70 mgm l -1) may activate a checkpoint immediately that
can affect foci formation drastically. Re-appearance of
ORC5 foci in some parasites and the increase in para-
sitemia in the presence of caffeine following HU treatment
may suggest that DNA damage checkpoint pathways
are active in the parasites. Interestingly, we have found
two ORFs in Plasmodium database (PF14-0516 and
PFB0815w respectively) that show considerable homol-
ogy with human Chk1 and Chk2 proteins. However, this
needs to be veriﬁed further.
DNA replication is a fundamental process from bacteria
to mammals. However, this important aspect of biology
has not been studied thoroughly except the model
systems like Escherichia coli, S. cerevisiae and Xenopus.
The thorough understanding of this process in protozoan
parasites like Plasmodium not only highlights the unique-
ness of these lower eukaryotes but also conﬁrms the
conserved role of the replication proteins among different
species. While the presence of previously un-noticed con-
served PIP domain in ScORC1, HsORC1 and PfORC1
ensures the conserved role of PCNA in DNA replication
among different species, the unique colocalization of
Replication foci in P. falciparum 661
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 69, 646–665ORC and PCNA forming replication foci and their separa-
tion following DNA replication clearly highlight important
aspect of DNA replication that has not been shown
earlier.
Finally, the identiﬁcation of a critical component of rep-
lication machinery in the parasites with nucleotide binding
and hydrolysis activities that are central to its function (as
found in S. cerevisiae) may be useful for ongoing search
for ﬁnding new targets for intervening Plasmodium growth
and proliferation.
Experimental procedures
Parasite culture
Plasmodium falciparum 3D7 strain was cultured in human O
+
erythrocytes in RPMI 1640 medium supplemented with
25 mM Hepes, 50 mg l
-1 hypoxanthine, 0.2% NaHCO3, 0.5%
Albumax (Invitrogen), 0.2% glucose and 10 mgm l
-1 gentamy-
cin sulphate. Synchronization of cultures was achieved by
using 5% sorbitol treatment of cells. Synchronization was
veriﬁed by morphological analysis of Giemsa-stained infected
blood smears at different time points.
For inhibitor studies, hydroxyurea (Sigma) was added into
the P. falciparum culture (5–6% parasitemia) at different
concentrations (0, 20, 40 and 70 mgm l
-1 respectively) at early
ring stage in triplicate. Samples were taken at different time
intervals following evaluation of developmental stages of the
parasites by Giemsa staining.
The proteasome inhibitor MG132 was added at a concen-
tration of 100 nM in synchronized P. falciparum (5–6% para-
sitemia) culture ~40 h post erythrocytic invasion in triplicate
and followed several hours thereafter.
RNA extraction and RT-PCR
RT-PCR reactions were performed using cDNA and speciﬁc
primers for PfORC5, PfMCM4, PfORC1 and control
PfGAPDH (Table S1, P15–P22) essentially following the
protocol as described elsewhere (Mehra et al., 2005). Semi-
quantitative analysis of RT-PCR results was performed by
densitometric quantiﬁcation of the ampliﬁed products fol-
lowed by graphical representation of these results.
ATPase and ATP binding assays
ATPase assay was performed using recombinant pGEX6P2-
PfORC5D1 (171–899 aa) protein (wild type or mutant) follow-
ing the protocol as described earlier (Mehra et al., 2005).
Thin-layer chromatography (TLC) was performed to separate
the released Pi.TheTLC plates were dried, autoradiographed
and quantiﬁed by Phosphorimager (Fujiﬁlm-BAS-1800).
For ATP binding assay, 1 mg of MBP-PfORC5D2 (171–
421 aa) protein (wild type or mutant) was cross-linked with
[a-
32P]-dATP in the presence of UV (254 nm) for 30 min in
30 ml reaction mixture containing 20 mM Hepes (pH 7.5), 10%
glycerol, 0.1 mM DTT, 10 mCi [a-
32P]-dATP (3000 Ci mmol
-1)
using a Stratagene cross-linker followed by addition of 0.8 ml
of100 mMdATPand20 mgofBSA.Proteinswereprecipitated
by trichloroacetic acid and the pellet was washed once with
acetonecontaining0.5%HClandtwicewithacetone.Proteins
were separated by SDS-PAGE and the radiolabelled dATP-
bound proteins were visualized using phosphorimager.
Immunoﬂuorescence assay
Thin smear of synchronous culture of infected erythrocytes
was made on glass slides. Slides were air-dried for 2 h at
room temperature followed by ﬁxation for 30 min in freshly
prepared solution of acetone and methanol (90% and 10%
respectively) at -20°C. The slides were further blocked for 1 h
at room temperature in 1¥ PBS containing 3% BSA and
0.01% saponin. Slides were then incubated overnight in
1¥ PBS containing respective primary antibodies at 4°C.
Immunoaffinity-puriﬁed anti-PfORC1 (rabbit), anti-PfORC5
(rabbit), anti-PfORC1 (mouse) and anti-PfPCNA1 (mouse)
antibodies were used at 1:500, 1:500, 1:2000 and 1:500
dilutions respectively, as primary antibodies. Slides were
further washed in 1¥ PBS and incubated for 45 min at 4°C in
1¥ PBS containing anti-rabbit IgG-Alexa ﬂour 488 or anti-
mouse IgG Alexa ﬂuor 594 (Molecular Probes) 1:1000 sec-
ondary antibodies and nuclear stain DAPI. Images were
captured using Nikon Eclipse 80i ﬂuorescent microscope.
Alternatively, glass slides containing parasites were incu-
bated in 2% PFA solution for 15 min at the room temperature
followed by blocking them in 0.5% BSAsolution in 1¥ PBS for
20 min. The slides were further treated with primary antibod-
ies for 2–3 h at room temperature and secondary antibodies
for 45 min with thorough washing with 1¥ PBS after each
antibody treatment. Antibody dilutions were kept the same as
above.
Immunoelectron microscopy
Immunoelectron microscopy for the subcellular localization
of PfORC5 was performed as described elsewhere (Mehra
et al., 2005) using anti-PfORC5 antibodies (1:500) as primary
antibodies and goat anti-rabbit IgG secondary antibodies
coupled with 10–20 nm gold particles at 1:100 dilution. Sec-
tions were viewed using a Morgagni-268 transmission elec-
tron microscope.
Immunoprecipitation assay
For Immunoprecipitation, lysate from 100 mlo fP. falciparum-
infected erythrocyte pellet (8–10% parasitemia) was pre-
pared by adding ﬁve to six pellet volume of lysis buffer
containing 300 mM NaCl, 20 mM Tris.Cl, pH 8.0 and 0.5%
NP-40 and anti-protease cocktail (Sigma). Lysate was clari-
ﬁed by centrifugation at 15 000 g for 30 min at 4°C. Either
pre-immune or immune sera (1–2 ml) were added to this
cleared lysate and the mixture was incubated at 4°C for 2 h
with constant mild shaking followed by addition of 20 mlo f
protein A sepharose slurry or protein G sepharose slurry
(Sigma). Finally, these bead Ab protein mixtures were incu-
bated for 1 h at 4°C. Beads were collected and washed three
times with 1¥ PBS containing 0.1% BSA. Immunoprecipitated
proteins were eluted from beads by adding 2 vols of SDS-
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were separated by SDS-PAGE and transferred onto PVDF
membrane and immunoblotted using corresponding primary
and secondary antibodies.
Complementation of yeast ORC5 mutant
Complementation experiments were performed in S. cerevi-
siae using either wild-type PfORC5 or S. cerevisiae ORC5 or
different chimeras of S. cerevisiae and P. falciparum ORC5.
Details of the methods are described in supplementary data,
Experimental procedures (yeast complementation section).
DNA manipulation
The putative PfORC5 gene was ampliﬁed by polymerase
chain reaction using P. falciparum 3D7 genomic DNA as a
template and speciﬁc primers (P1 and P2, Table S1). For the
detailed cloning strategy of wild-type and mutant forms of
PfORC5andPfPCNA,pleaseseesupplementaryinformation.
Recombinant protein puriﬁcation
For the puriﬁcation of PfORC5 fusion recombinant proteins
to perform ATP binding and hydrolysis assay, E. coli BL21
codon-plus strain was transformed with respective recombi-
nant clones. Of all the constructs made to express recombi-
nant proteins, only pGEX6P2-PfORC5D1 (171–899 aa) and
pMALc2¥-PfORC5D2 (171–421 aa) yielded the recombinant
proteins in soluble form. The detailed methods for protein
puriﬁcation for these constructs and other constructs for anti-
bodies preparation (PfORC5C1 and PfORC5C2) are de-
scribed in supplementary information, materials and methods.
Antibody production and Western blotting analysis
Polyclonal antibodies against different antigens in rabbit
and mice were generated essentially following the protocol
described by Harlow and Lane (1988). Please see supple-
mentary information for detailed protocols.
Western blot analysis was carried out following the stan-
dard protocol (Sambrook et al., 1989). Please see supple-
mentary information for the details.
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